1531 - 1540 of 8571 Results
Title
Year
- Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study2019RESTRICTEDTitle: Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 70Issue #:Start Page: 51End Page: 54Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.008Citation Count: 34
- Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration2019OPENTitle: Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 49End Page: 59Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.196Best OA location URL: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.jalz.2019.08.196Citation Count: 36
- Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons2021OPENTitle: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 156Issue #:Start Page: 105409End Page: 105409Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105409Citation Count: 27
- A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein2018OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 52
-
RESTRICTEDTitle: Parkinson's Disease Gene Screening in Familial Cases from Central and South AmericaJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 10Start Page: 1843End Page: 1855Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29931Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdf/10.1002/mds.29931Citation Count: 2
- Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease2023OPENTitle: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s diseaseJournal Name: Communications MedicinePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s43856-023-00294-wBest OA location URL: https://www.nature.com/articles/s43856-023-00294-w.pdfCitation Count: 30
-
OPENTitle: An Expanded Polyproline Domain Maintains Mutant Huntingtin Soluble in vivo and During AgingJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.721749Best OA location URL: https://doi.org/10.3389/fnmol.2021.721749Citation Count: 13
- Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease2023OPENTitle: Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-45078-3Best OA location URL: https://www.nature.com/articles/s41598-023-45078-3.pdfCitation Count: 8
- Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity2022OPENTitle: Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00388-7Best OA location URL: https://www.nature.com/articles/s41531-022-00388-7.pdfCitation Count: 42
-
OPENTitle: Impaired hepatic amyloid-beta degradation in Alzheimer’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 13Issue #: 9Start Page: e0203659End Page: e0203659Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0203659Best OA location URL: https://doi.org/10.1371/journal.pone.0203659Citation Count: 70